HK Stock Market Move | EXTREME VISION (06636) rises over 4%, partners with GK SuperTech to jointly expand into the Southeast Asian AI market; the company has officially been approved for inclusion in the Stock Connect.
EXTREME VISION (06636) rose over 4% in late trading, and as of press time, was up 2.19% at HK$69.85, with a turnover of HK$20.9798 million.
EXTREME VISION (06636) rose over 4% in late trading, up 2.19% as of press time at HK$69.85, with a turnover of HK$20.9798 million.
On the news front, recently, according to EXTREME VISION's official WeChat account, the company announced in Kuala Lumpur a strategic partnership with GK SuperTech Sdn Bhd (GKST), a subsidiary of Malaysian-listed company George Kent (Malaysia) Berhad that focuses on artificial intelligence and industrial automation businesses. The two parties will engage in deep collaboration across two major directions: co-building AI benchmark scenarios and regional business cooperation layout, jointly seizing the rapid growth opportunities in Southeast Asia's artificial intelligence and smart infrastructure sectors.
Previously, EXTREME VISION was officially approved for inclusion in the Stock Connect. According to EXTREME VISION's disclosed financial report for the first half of 2026, the company's revenue was 165 million yuan, a year-on-year increase of 181.2%; among which, revenue from large model solutions reached 84.8 million yuan, a significant year-on-year increase of 4540%; adjusted net profit successfully turned profitable; during the same period, R&D investment was 47.8 million yuan, a year-on-year increase of 35.1%, with R&D efforts continuing to intensify.
Related Articles

Zhejiang Wecome Pharmaceutical (300878.SZ): Huangjia Ruangan Granules Approved to Initiate Phase III Clinical Trial for Liver Fibrosis in Chronic Hepatitis B

Global iron ore export hub Group, Inc. Class A pay dispute remains unresolved! BHP Group Ltd Sponsored American Depositary Receipt Repr 2 Shs (BHP.US) Port Hedland workers to seek arbitration over pay agreement dispute.

Jefferies: S&P 500 Index expected to target 8,000 by end-2026, with a potential rise to 9,000 by end-2027.
Zhejiang Wecome Pharmaceutical (300878.SZ): Huangjia Ruangan Granules Approved to Initiate Phase III Clinical Trial for Liver Fibrosis in Chronic Hepatitis B

Global iron ore export hub Group, Inc. Class A pay dispute remains unresolved! BHP Group Ltd Sponsored American Depositary Receipt Repr 2 Shs (BHP.US) Port Hedland workers to seek arbitration over pay agreement dispute.

Jefferies: S&P 500 Index expected to target 8,000 by end-2026, with a potential rise to 9,000 by end-2027.

RECOMMEND





